ACE Inhibitors - Pril's Power Play

- Mechanism: Inhibit Angiotensin Converting Enzyme (ACE) to block Angiotensin I → Angiotensin II conversion. Also prevents bradykinin breakdown.
- Result: ↓ Angiotensin II leads to vasodilation & ↓ aldosterone. ↑ Bradykinin contributes to vasodilation and side effects.
- Key Side Effects: Dry cough, angioedema (↑ bradykinin), hyperkalemia, first-dose hypotension.
- Contraindications: Pregnancy (teratogen), bilateral renal artery stenosis.
- Mnemonic (📌): Captopril's CATCHH (Cough, Angioedema, Teratogen, Creatinine ↑, Hyperkalemia, Hypotension).
⭐ ACE inhibitors are first-line therapy for hypertension with compelling indications like diabetes mellitus (for diabetic nephropathy) and chronic kidney disease.
Angiotensin II Receptor Blockers - Sartan's Shield
- Mechanism: Selectively block the Angiotensin II Type 1 (AT1) receptor.
- Inhibits the primary effects of Angiotensin II, leading to arterial/venous dilation and ↓ aldosterone secretion.
- Drugs: Losartan, Valsartan, Irbesartan (ends in -sartan).
- Key Advantage vs. ACEi: Do not increase bradykinin levels.
- Results in a much lower risk of cough and angioedema.
⭐ ARBs are a first-line substitute for patients who cannot tolerate ACE inhibitors due to cough.
- Adverse Effects:
- Hyperkalemia
- Hypotension
- ⚠️ Teratogenic: Contraindicated in pregnancy.
Pathway Bookends - Renin & Aldosterone Blockers
-
Direct Renin Inhibitor: Aliskiren
- Mechanism: Directly blocks renin, preventing the conversion of angiotensinogen to angiotensin I.
- Side Effects: Can cause hyperkalemia, hypotension, and acute kidney injury.
- Contraindications: Similar to ACE inhibitors and ARBs, especially pregnancy.
-
Aldosterone Antagonists
- Drugs: Spironolactone, Eplerenone.
- Mechanism: Compete with aldosterone for receptors in the distal convoluted tubule and collecting duct.
- Side Effects:
- Hyperkalemia is a major risk.
- Spironolactone: Can cause gynecomastia, impotence, and menstrual irregularities due to its antiandrogen effects.
- Eplerenone: More selective for the mineralocorticoid receptor, with fewer antiandrogen side effects.
⭐ Spironolactone is particularly useful in managing ascites secondary to liver cirrhosis and in heart failure to improve survival.

Comparative Side Effects - The RAAS Clash
| Side Effect | ACE Inhibitors (-pril) | ARBs (-sartan) | Aldosterone Antagonists |
|---|---|---|---|
| Cough | Yes (↑ Bradykinin) | No | No |
| Angioedema | Yes (↑ Bradykinin) | Lower Risk | No |
| Hyperkalemia | Yes | Yes | Yes (significant) |
| Teratogenicity | Yes | Yes | No |
| Gynecomastia | No | No | Yes (Spironolactone) |
High‑Yield Points - ⚡ Biggest Takeaways
- ACE inhibitors (-prils) prevent Angiotensin I conversion, causing dry cough & angioedema due to increased bradykinin.
- ARBs (-sartans) block AT1 receptors directly, making them a suitable alternative for patients with ACE inhibitor-induced cough.
- Aliskiren is a direct renin inhibitor, blocking the rate-limiting step of the RAAS pathway.
- Aldosterone antagonists (e.g., spironolactone) are K+-sparing diuretics; major side effects include hyperkalemia and gynecomastia.
- ACE inhibitors and ARBs are potent teratogens and are absolutely contraindicated in pregnancy.
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING — FREEor get the app